Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery

• Published in: Molecules (Basel, Switzerland) Switzerland), 2018-01, Vol.23 (1), p.102
• Main Authors: Honegr, Jan, Dolezal, Rafael, Malinak, David, Benkova, Marketa, Soukup, Ondrej, Almeida, Joyce S F D de, Franca, Tanos C C, Kuca, Kamil, Prymula, Roman
• Format: Article
• Language: English
• Subjects: Binding sites; High-throughput screening; Interleukin 6; Lipid A; Monophosphoryl lipid A; Surface plasmon resonance; TLR4 protein; Toll-like receptors; Tryptamine; Tryptamines
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules23010102

In order to identify novel lead structures for human toll-like receptor 4 ( TLR4) modulation virtual high throughput screening by a peta-flops-scale supercomputer has been performed. Based on the in silico studies, a series of 12 compounds related to tryptamine was rationally designed to retain suitable molecular geometry for interaction with the TLR4 binding site as well as to satisfy general principles of drug-likeness. The proposed compounds were synthesized, and tested by in vitro and ex vivo experiments, which revealed that several of them are capable to stimulate TLR4 in vitro up to 25% activity of Monophosphoryl lipid A. The specific affinity of the in vitro most potent substance was confirmed by surface plasmon resonance direct-binding experiments. Moreover, two compounds from the series show also significant ability to elicit production of interleukin 6.